Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Balkissoon

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
Journal Club: Inhaled Corticosteroids- Refining Our Understanding of Their Role in Maintenance Treatment for COPDRon Balkissoon
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|October 28, 2021
Journal Club: Non-invasive Mechanical Ventilation in Stable COPDTakudzwa Mkorombindo, Ron Balkissoon
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|July 29, 2022
Journal Club: Impaired Ventilatory Efficiency and Exercise Intolerance in Former/Current Smokers With Dyspnea Disproportionate to Their Lung Function: Pathophysiological Insights Gained Through Cardiopulmonary Exercise TestingRon Balkissoon, Takudzwa Mkorombindo
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|January 28, 2022
Journal Club-Respiratory Impairment With A Preserved Spirometric RatioTakudzwa Mkorombindo, Ron Balkissoon
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 29, 2022
Journal Club: Biologics and Potential for Immune Modulation in Chronic Obstructive Lung DiseaseTakudzwa Mkorombindo, Ron Balkissoon
Seminars in Respiratory and Critical Care Medicine|October 11, 2012
Asthma: vocal cord dysfunction (VCD) and other dysfunctional breathing disordersRon Balkissoon, Klaus Kenn
COPD|September 26, 2006
COPD and air travelRon Balkissoon, Enrique Fernandez
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|July 30, 2021
Journal Club: Respiratory Impact of Wildfire SmokeTakudzwa Mkorombindo, Ron Balkissoon
COPD|August 2, 2008
A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary diseaseRon Balkissoon, Barry Make
The Medical Clinics of North America|October 29, 2011
Chronic obstructive pulmonary disease: a concise reviewRon Balkissoon, Steve Lommatzsch, Brendan Carolan, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
Journal Club: Inhaled Corticosteroids- Refining Our Understanding of Their Role in Maintenance Treatment for COPDRon Balkissoon
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|October 28, 2021
Journal Club: Non-invasive Mechanical Ventilation in Stable COPDTakudzwa Mkorombindo, Ron Balkissoon
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|July 29, 2022
Journal Club: Impaired Ventilatory Efficiency and Exercise Intolerance in Former/Current Smokers With Dyspnea Disproportionate to Their Lung Function: Pathophysiological Insights Gained Through Cardiopulmonary Exercise TestingRon Balkissoon, Takudzwa Mkorombindo
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|January 28, 2022
Journal Club-Respiratory Impairment With A Preserved Spirometric RatioTakudzwa Mkorombindo, Ron Balkissoon
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 29, 2022
Journal Club: Biologics and Potential for Immune Modulation in Chronic Obstructive Lung DiseaseTakudzwa Mkorombindo, Ron Balkissoon
Seminars in Respiratory and Critical Care Medicine|October 11, 2012
Asthma: vocal cord dysfunction (VCD) and other dysfunctional breathing disordersRon Balkissoon, Klaus Kenn
COPD|September 26, 2006
COPD and air travelRon Balkissoon, Enrique Fernandez
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|July 30, 2021
Journal Club: Respiratory Impact of Wildfire SmokeTakudzwa Mkorombindo, Ron Balkissoon
COPD|August 2, 2008
A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary diseaseRon Balkissoon, Barry Make
The Medical Clinics of North America|October 29, 2011
Chronic obstructive pulmonary disease: a concise reviewRon Balkissoon, Steve Lommatzsch, Brendan Carolan, et al.
Pageof 4